Disease: Triple-negative breast cancer  
Disease: triple negative breast cancer  
AssayName: phosphoproteomics  
AssayName: high-throughput phosphoproteomics  
CellLine: MDA-MB-231  
CellLine: MDA-MB-157  
CellLine: Hs578T  
CellLine: MDA-MB-468  
CellLine: HCC1937  
CellLine: HCC1143  
CellLine: HCC38  
CellLine: BT549  
CellLine: BT483  
CellLine: MDA-MB-415  
CellLine: HEK 293T cells  
GeneticModification: stable transfection with a plasmid encoding firefly luciferase (pGL.4.51 luciferase reporter vector, Promega)  
CleavageAgent: trypsin  
CleavageAgent: endoproteinase Lys-C  
AlkylationReagent: 30 mM chloro-acetamide  
AlkylationReagent: 50 mM IAA solution  
ReductionReagent: 15 mM TCEP  
ReductionReagent: 10 mM DTT  
EnrichmentMethod: Ti4-IMAC chromatography  
FragmentationMethod: higher-energy collisional dissociation (HCD)  
FragmentationMethod: ion trap CID  
FragmentationMethod: ETD fragmentation  
PrecursorMassTolerance: 10 ppm  
FragmentMassTolerance: 0.025 Da  
Instrument: Q Exactive Plus mass spectrometer  
Instrument: UltiMate 3000 HPLC system  
Instrument: LTQ-Orbitrap Elite  
Instrument: Proxeon EASY-nLC 1000  
IonizationType: electrospray  
AcquisitionMethod: data-dependent mode  
GradientTime: 60 min effective curved gradient  
GradientTime: 90-min gradient  
FlowRateChromatogram: 10 µl/min  
FlowRateChromatogram: 250 nL/min  
NumberOfMissedCleavages: 2  
NumberOfSamples: n = 34 patients  
Organism: Homo sapiens  
Organism: Hsd: Athymic Nude-Foxn1nu  
Sex: female  
TumorCellularity: >75% tumor content  
TumorSite: mammary fat pad  
TumorSite: lower flank  
Treatment: palbociclib  
Treatment: GDC-0994  
Treatment: Imatinib  
NumberOfTechnicalReplicates: 3  
Time: 30 min  
Time: 45 min  
Time: overnight  
Time: 4 h  
Time: 90 min  
Temperature: 30 °C  
Temperature: 45 °C  
Temperature: 37 °C